CancerCare: Myelodysplastic Syndromes

Not Funded
About
CancerCare: Myelodysplastic Syndromes offers comprehensive support for patients in active treatment for myelodysplastic syndromes. With a focus on covering critical medications like Gleevec, Jakafi, and Revlimid, CancerCare provides up to $10,000 in assistance for co-payments and coinsurance, as well as treatment-related expenses, ensuring affordability and accessibility of care.
Insurance requirements: Commercially insured, Medicare / Medicaid
Enrollment Forms
Enrollment Form
Benefits
$10000 annual maximum benefit
Program Requirements
Valid only for residents in the US and Puerto Rico
Enrollment Required: Yes
Coverage Required: No
Needs Based: Yes
Activation Required: No
Program Details
Please note the following:
1. CancerCare covers any cancer drugs that are covered by the patient’s primary insurance and that are included in the NCCN guidelines for that cancer diagnosis
2. Patients with private insurance must apply to manufacturer programs first before they apply to CancerCare
Patients can enroll online but should first call 18008134673 to speak with a CancerCare social worker for a brief interview (MonThurs 10am6pm ET, and Fri 10am5pm ET)
If eligible, patients will be mailed/emailed an individualized barcoded application and income documentation will be requested
Patients must then submit their completed application forms and requested documentation by uploading the information to their patient portal, or via fax or email to the correct CancerCare fax number or email address listed on the application
Acceptable income documentation includes the first 2 pages of signed income tax return, copy of most recent pay stub, unemployment check, or SSI, SSD, or public assistance benefit notification. Applicants without any source of income may provide a letter of support from friend or family member
Grants are renewable; CancerCare will reach out to patients 60 days before the end of their term (enrollment is 12 months rolling – not based on calendar year)
Program has funding to cover copayment and coinsurance for chemotherapy or targeted treatment medications only; any charges for scans, radiation or symptom management medicines are not covered
Program can also assist with treatmentrelated expenses such as transportation, home care, and childcare costs; See the following link: https://www.cancercare.org/financial
Initial grant amount is $5,000; maximum grant amount is $10,000
Diagnosis Codes: ICD10: D46, D46.0, D46.1, D46.2, D46.20, D46.21, D46.22, D46.A, D46. B, D46. C, D46.4, D46.Z, D46.9
Other Programs
HealthWell: Myelodysplastic Syndromes - Medicare Access
Rytelo at no costSee program details for eligibility
REACH4RYTELO Copay Program
Pay as little as $0/monthUp to $10,650/year in savings
Other Tools for Rytelo